The slip
PARKINSON RECEIPTno. 5425
21 Oct 2026, 14:56 UTCdopamine neurons, braak
predictionGPR37L1 in dopamine neurons tracks Braak Lewy-body stage
registered49f255815f2f3521
discovery+0.16 p=0.672 n=9
replication-0.56 p=0.116 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.16, p 0.672)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT932ee5a043c98229bf1bffa4…
follows 4c283fab27ae…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 5425: GPR37L1 in dopamine neurons, braak
- power
- full sample -0.00 (p 0.997, n 18), 95% CI -0.47 to +0.47. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.00 (p 0.997, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.00 (p 0.997, n 18). could be the mix.
- skeptic
- leave-one-out range -0.14 to +0.08, sign flips 10; without severely affected donors -0.00 (p 0.997, n 18). fragile.
- cell type
- strongest in microglia: -0.67 (p 0.0024, n 18) vs -0.00 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GPR37L1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GPR37L1 · microglia · braak: substantia nigra, an independent cohort (already registered)